SCHEMBL4615984

SCHEMBL4615984

NC1CCN(C(=O)c2ccc(N3CCCC3)nc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
HPGD P15428 2/20 0.62
KDM4E B2RXH2 1/20 0.62
POLB P06746 1/20 0.62
ALOX15 P16050 1/20 0.62
HSD17B10 Q99714 1/20 0.62
ADRA1A P35348 8/20 0.57
UBE2T Q9NPD8 1/20 0.54
L3MBTL3 Q96JM7 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MGLL Q99685 1/20 0.50
FASN P49327 4/20 0.48
SFRP1 Q8N474 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
HPGDS O60760 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6139577 0.93 ALDH1A1 (0.68) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL4618663 0.88 ALDH1A1 (0.78) ALDH1A1HPGDKDM4EPOLBALOX15
Trifluoroacetic Acid SCHEMBL6824444 0.87 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL6821107 0.82 ALDH1A1 (0.67) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL4617450 0.81 PROKR1 (0.59) ALDH1A1HPGDPOLBL3MBTL3L3MBTL1
SCHEMBL14085084 0.81 ALDH1A1 (0.65) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL13779979 0.81 POLB (0.65) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL601333 0.80 HRH3 (0.54) ALDH1A1KDM4EUBE2TSMN1; SMN2
SCHEMBL6140027 0.80 HRH3 (0.58) ALDH1A1KDM4EUBE2T
SCHEMBL13648899 0.80 ALDH1A1 (0.64) ALDH1A1HPGDKDM4EPOLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008061016-A1 N-SUBSTITUTED PIPERIDINYL 4 -ARYLSULFONAMIDES AS MODULATORS OF THE SECRETED FRIZZLED RELATED PROTEIN- 1 WYETH (US) 2008-05-22 WO disclosed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 ALDH1A1 1865/4885HPGD 2925/4885KDM4E 3044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.